Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
General Physician
M.B.B.S., MRCGP (UK)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Internal Medicine Specialist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Internal Medicine Specialist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MHPE (Masters in Health Professions Education)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MHPE (Masters in Health Professions Education)
Internal Medicine Specialist
MBBS, FCPS (Medicine), Diploma in Family Medicine, FRCP Gladgow (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine), Diploma in Family Medicine, FRCP Gladgow (UK)
Gastroenterologist
M.B.B.S, F.C.P.S. (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures